RxDoctor Payments Data

Spyridon Akrivakis, MD

Clinical Cardiac Electrophysiology · Bangor, MENPI 1508047481

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,662 of the $6,753 with a category attached, or 69.0%. 6 manufacturers reported payments, led by Medtronic at 54.3% of the total. 2025 is the largest year on record at $6,219, more than ten times the $31 reported in 2019.

$6,753in general payments, 2019–2025

Across 52 payments — averaging $129.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$2K
  • Atricure, Inc.$363
  • Biotronik Inc.$254
  • Biosense Webster, Inc.$77
  • Edwards Lifesciences$31
$160,721in research payments, 2019–2025

Across 217 payments — averaging $740.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$70K
  • Elutia, Inc.$55K
  • Biotronik Inc.$30K
  • Abbott$6K

What the payments were for

  • Travel & lodging$4,66269%
  • Food & beverage$2,09231%

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical cardiac electrophysiology providers in Maineto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$145,308
Medicare patients
846
Services billed
1,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MultaqDronedarone Hcl31$54,829
EliquisApixaban25$38,513
JardianceEmpagliflozin21$25,175
Dofetilide91$20,555
EntrestoSacubitril/Valsartan12$15,475
Flecainide Acetate69$5,308
SotalolSotalol Hcl111$2,926
Mexiletine Hcl14$2,274
Amiodarone Hcl110$2,041
Furosemide70$344
Metoprolol Succinate26$274
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$182
Spironolactone42$176
Amlodipine Besylate13$119
Losartan Potassium15$49

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Bangor

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →